JBIO · Jade Biosciences, Inc.
$19.67
-1.19 (-5.70%)
At close · Jul 20
Going-concern doubt
— flagged May 7, 2026
Substantial doubt about the company's ability to continue as a going concern.
“We will still need to raise additional capital to continue to fund our operations in the future. If we are unable to raise additional capital when needed, that could raise substantial doubt about our ability to continue as a going concern.”View the 10-Q filed May 7, 2026
Market Cap
$1.01B
Shares
49.36M
Total shares sold short and not yet covered, reported to FINRA by broker-dealers and published twice a month (bi-monthly). Days to cover divides the short position by average daily volume; a high value (above 5) can signal short-squeeze potential.
Short Squeeze Score
75/100
Short interest 16.5% of shares — P96
Days to cover 4.9 — P79
Price vs VWAP -3.3% — P43
Short-volume trend -1.1% — P47
Short interest change +64.7% — P90
Worst FTD 0.10% of shares — P75
Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-06-30). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.
Short Interest History
| Settlement Date | Current Position | Previous Position | Change | Days to Cover |
|---|---|---|---|---|
| 2026-06-30 | 8,148,753 | 4,947,659 | +3,201,094 | 4.85 |
| 2026-06-15 | 4,947,659 | 3,163,082 | +1,784,577 | 3.10 |
| 2026-05-29 | 3,163,082 | 3,398,202 | -235,120 | 5.43 |
| 2026-05-15 | 3,398,202 | 3,097,060 | +301,142 | 7.66 |
| 2026-04-30 | 3,097,060 | 3,061,277 | +35,783 | 3.96 |
| 2026-04-15 | 3,061,277 | 1,251,725 | +1,809,552 | 3.78 |
| 2026-03-31 | 1,251,725 | 1,534,939 | -283,214 | 2.26 |
| 2026-03-13 | 1,534,939 | 1,561,572 | -26,633 | 4.40 |
| 2026-02-27 | 1,561,572 | 1,558,822 | +2,750 | 7.31 |
| 2026-02-13 | 1,558,822 | 1,446,919 | +111,903 | 6.88 |
| 2026-01-30 | 1,446,919 | 1,345,619 | +101,300 | 5.65 |
| 2026-01-15 | 1,345,619 | 1,546,739 | -201,120 | 4.28 |
| 2025-12-31 | 1,546,739 | 1,046,137 | +500,602 | 3.32 |
| 2025-12-15 | 1,046,137 | 1,165,100 | -118,963 | 3.27 |
| 2025-11-28 | 1,165,100 | 1,069,346 | +95,754 | 5.16 |
| 2025-11-14 | 1,069,346 | 1,029,313 | +40,033 | 4.83 |
| 2025-10-31 | 1,029,313 | 1,705,247 | -675,934 | 5.43 |
| 2025-10-15 | 1,705,247 | 1,756,044 | -50,797 | 8.06 |
| 2025-09-30 | 1,756,044 | 1,743,879 | +12,165 | 24.59 |
| 2025-09-15 | 1,743,879 | 1,807,489 | -63,610 | 30.79 |
| 2025-08-29 | 1,807,489 | 1,900,704 | -93,215 | 16.83 |
| 2025-08-15 | 1,900,704 | 1,819,583 | +81,121 | 18.37 |
| 2025-07-31 | 1,819,583 | 1,865,916 | -46,333 | 13.38 |
Showing 1–23 of 23 settlements
Key facts
CIK
1798749
CUSIP
008064206
13F (30d)
11 filings
11 filers
Visit website
Investor relations